Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	936.88	120.94	-11.66
Graham Fair Price	-64.76	1487.04	4219.32
PEG	-2091.58	-0.09	< 0.005
Price/Book	-30.23	0.62	0.89
Price/Cash Flow	47.44	-10.05	-19.12
Prices/Earnings	479.30	10.15	-1.75
Price/Sales	-20.06	1.20	1.50
Price/FCF	47.44	-10.05	-19.12
Naive Interpretation	member

01 - Valuation · Somewhat Positive

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	15.27	0.09	-0.08
Operating Margin	-94.91	0.02	-0.32
ROA	-88.17	< 0.005	-0.04
ROE	-0.13	0.02	-87.96
ROIC	-0.06	< 0.005	-95.63
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.05	0.01	213.71
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-6.47	1.05	-83.84
EPS QOQ	-4.25	1.12	-73.57
FCF QOQ	-1.99	-0.35	82.50
Revenue QOQ	0.27	-0.11	-57.55
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	70.33	94.74	34.72
Days Sales Outstanding (DSO)	88.52	108.11	22.14
Inventory Turnover	1.28	0.95	-25.77
Debt/Capitalization	0.54	0.55	1.35
Quick Ratio	0.32	0.33	3.04
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	2497.58	2536.33	1.55
Cash	15.94	19.40	21.67
Capex	4.08	-3.41	-16.49
Free Cash Flow	-116.13	-156.56	-34.81
Revenue	1479.47	1311.41	-11.36
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	0.71	0.72	1.46
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-6.68	80.28	1101.97
Naive Interpretation	Member

06 - Financial Health · Bad

Rating